Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

SOD2 and the Mitochondrial UPR: Partners Regulating Cellular Phenotypic Transitions.

He C, Hart PC, Germain D, Bonini MG.

Trends Biochem Sci. 2016 Jul;41(7):568-77. doi: 10.1016/j.tibs.2016.04.004. Epub 2016 May 11. Review.

PMID:
27180143
2.

The NF-κB Pathway and Cancer Stem Cells.

Rinkenbaugh AL, Baldwin AS.

Cells. 2016 Apr 6;5(2). pii: E16. doi: 10.3390/cells5020016. Review.

3.

CSCdb: a cancer stem cells portal for markers, related genes and functional information.

Shen Y, Yao H, Li A, Wang M.

Database (Oxford). 2016 Mar 17;2016. pii: baw023. doi: 10.1093/database/baw023. Print 2016.

4.

Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies.

Sainz B Jr, Carron E, Vallespinós M, Machado HL.

Mediators Inflamm. 2016;2016:9012369. doi: 10.1155/2016/9012369. Epub 2016 Feb 14. Review.

5.

Biological and clinical significance of cancer stem cell plasticity.

Zhu Y, Luo M, Brooks M, Clouthier SG, Wicha MS.

Clin Transl Med. 2014 Dec;3(1):32. doi: 10.1186/s40169-014-0032-3. Epub 2014 Oct 7.

6.

Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancer.

Hsu EC, Kulp SK, Huang HL, Tu HJ, Chao MW, Tseng YC, Yang MC, Salunke SB, Sullivan NJ, Chen WC, Zhang J, Teng CM, Fu WM, Sun D, Wicha MS, Shapiro CL, Chen CS.

Carcinogenesis. 2016 Apr;37(4):430-42. doi: 10.1093/carcin/bgw020. Epub 2016 Feb 19.

PMID:
26905583
7.

New Findings on Breast Cancer Stem Cells: A Review.

Bozorgi A, Khazaei M, Khazaei MR.

J Breast Cancer. 2015 Dec;18(4):303-12. doi: 10.4048/jbc.2015.18.4.303. Epub 2015 Dec 23. Review.

8.

Targeting the Notch signaling pathway in cancer therapeutics.

Guo H, Lu Y, Wang J, Liu X, Keller ET, Liu Q, Zhou Q, Zhang J.

Thorac Cancer. 2014 Nov;5(6):473-86. doi: 10.1111/1759-7714.12143. Epub 2014 Oct 23. Review.

9.

Role of a polyphenol-enriched preparation on chemoprevention of mammary carcinoma through cancer stem cells and inflammatory pathways modulation.

Vuong T, Mallet JF, Ouzounova M, Rahbar S, Hernandez-Vargas H, Herceg Z, Matar C.

J Transl Med. 2016 Jan 14;14:13. doi: 10.1186/s12967-016-0770-7.

10.

Cancer Stem Cell Plasticity Drives Therapeutic Resistance.

Doherty MR, Smigiel JM, Junk DJ, Jackson MW.

Cancers (Basel). 2016 Jan 5;8(1). pii: E8. doi: 10.3390/cancers8010008. Review.

11.

Multiple regulation pathways and pivotal biological functions of STAT3 in cancer.

Yuan J, Zhang F, Niu R.

Sci Rep. 2015 Dec 3;5:17663. doi: 10.1038/srep17663.

12.

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.

Wee ZN, Yatim SM, Kohlbauer VK, Feng M, Goh JY, Bao Y, Lee PL, Zhang S, Wang PP, Lim E, Tam WL, Cai Y, Ditzel HJ, Hoon DS, Tan EY, Yu Q.

Nat Commun. 2015 Oct 27;6:8746. doi: 10.1038/ncomms9746. Erratum in: Nat Commun. 2015;6:10054. Yi, Bao [Corrected to Bao, Yi].

13.

Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.

Sehl ME, Shimada M, Landeros A, Lange K, Wicha MS.

PLoS One. 2015 Sep 23;10(9):e0135797. doi: 10.1371/journal.pone.0135797. eCollection 2015.

14.

Head and Neck Cancer Stem Cells: From Identification to Tumor Immune Network.

Dionne LK, Driver ER, Wang XJ.

J Dent Res. 2015 Nov;94(11):1524-31. doi: 10.1177/0022034515599766. Epub 2015 Aug 7. Review.

PMID:
26253189
15.

ARTD1 Suppresses Interleukin 6 Expression by Repressing MLL1-Dependent Histone H3 Trimethylation.

Minotti R, Andersson A, Hottiger MO.

Mol Cell Biol. 2015 Sep;35(18):3189-99. doi: 10.1128/MCB.00196-15. Epub 2015 Jul 6.

16.

Endogenous molecular network reveals two mechanisms of heterogeneity within gastric cancer.

Li S, Zhu X, Liu B, Wang G, Ao P.

Oncotarget. 2015 May 30;6(15):13607-27.

17.

A multi-targeted approach to suppress tumor-promoting inflammation.

Samadi AK, Bilsland A, Georgakilas AG, Amedei A, Amin A, Bishayee A, Azmi AS, Lokeshwar BL, Grue B, Panis C, Boosani CS, Poudyal D, Stafforini DM, Bhakta D, Niccolai E, Guha G, Vasantha Rupasinghe HP, Fujii H, Honoki K, Mehta K, Aquilano K, Lowe L, Hofseth LJ, Ricciardiello L, Ciriolo MR, Singh N, Whelan RL, Chaturvedi R, Ashraf SS, Shantha Kumara HM, Nowsheen S, Mohammed SI, Keith WN, Helferich WG, Yang X.

Semin Cancer Biol. 2015 Dec;35 Suppl:S151-84. doi: 10.1016/j.semcancer.2015.03.006. Epub 2015 May 5. Review.

18.

Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment.

Li P, Shan JX, Chen XH, Zhang D, Su LP, Huang XY, Yu BQ, Zhi QM, Li CL, Wang YQ, Tomei S, Cai Q, Ji J, Li JF, Chouchane L, Yu YY, Sun FZ, Xu ZH, Liu BY, Zhu ZG.

Cell Res. 2015 May;25(5):588-603. doi: 10.1038/cr.2015.51. Epub 2015 Apr 28.

19.

EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.

Sato F, Kubota Y, Natsuizaka M, Maehara O, Hatanaka Y, Marukawa K, Terashita K, Suda G, Ohnishi S, Shimizu Y, Komatsu Y, Ohashi S, Kagawa S, Kinugasa H, Whelan KA, Nakagawa H, Sakamoto N.

Cancer Biol Ther. 2015;16(6):933-40. doi: 10.1080/15384047.2015.1040959. Epub 2015 Apr 21.

20.

Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.

Pan Q, Li Q, Liu S, Ning N, Zhang X, Xu Y, Chang AE, Wicha MS.

Stem Cells. 2015 Jul;33(7):2085-92. doi: 10.1002/stem.2039. Epub 2015 May 13. Review.

Items per page

Supplemental Content

Write to the Help Desk